secwatch.observer — SEC 8-K summary
======================================

Issuer:     Incannex Healthcare Inc. (IXHL)
CIK:        0001873875
Form:       8-K
Filed at:   2026-06-10T11:30:39+00:00
Accession:  0001213900-26-067081
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Incannex receives A$6M R&D tax refund; expects another A$5.1M in 2026
---------------------------------------------------------------------

- Received A$6,039,162 under Australian Government's R&D Tax Incentive Program for FY25.
- Expects additional ~A$5.1M later in 2026, total >A$11.1M non-dilutive capital received this year.
- Non-dilutive refund strengthens balance sheet, supports clinical programs (IHL-42X, PSX-001) and share repurchase.
- CEO states refund obtained without issuing shares; company remains debt-free.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1873875/000121390026067081/0001213900-26-067081-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1873875/000121390026067081/ea0293917-8k_incannex.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-067081

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer